Clinical Trials on Type 2 Diabetes Mellitus in Obese in China

Total 888 results

AstraZeneca
Eli Lilly and Company

Completed

Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

Type 2 Diabetes Mellitus

United States, Czech Republic, France, Korea, Republic of, Russian Federation, Spain, Mexico, Australia, Belgium, Denmark, Germany, Hungary, Netherlands, Puerto Rico, Greece, Taiwan
Novo Nordisk A/S

Completed

Observational Study of NovoPen® 4 on Treatment Satisfaction of Insulin Therapy in Type 1 or Type 2 Subjects With Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

China
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

China
Otsuka Beijing Research Institute

Completed

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Type 2 Diabetes Mellitus | Arteriosclerosis Obliterans

China
Shanghai 6th People's Hospital

Unknown

Effect of Paired Testing to Poorly Controlled Chinese Diabetes on Glycemic Control and Self Care

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Shen Qu

Recruiting

Prolactin and FGF21 in Gestational Diabetes Mellitus

Gestational Diabetes Mellitus in Pregnancy | Hyperprolactinemia Pregnancy

China
Eli Lilly and Company

Completed

A Study of LY900014 Compared to Insulin Lispro in Participants With Type 2 Diabetes (PRONTO-T2D)

Type 2 Diabetes Mellitus

United States, Hungary, Puerto Rico, Spain, Australia, Korea, Republic of, Mexico, Japan, Germany, Russian Federation, Taiwan, Slovakia, Argentina, Czechia, India, Italy
Janssen Research & Development, LLC

Completed

A Efficacy, Safety, and Tolerability Study of Canagliflozin in Patients With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin Alone or in Combination With a Sulphonylurea

Diabetes Mellitus, Type 2

China, Malaysia, Vietnam
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, Parallel Controlled Clinical Trial

Type 2 Diabetes Mellitus | Mild Cognitive Impairment

China
AstraZeneca
Ono Pharmaceutical Co. Ltd

Completed

DISCOVERing Treatment Reality of Type 2 Diabetes in Real World Setting in Japan (J-DISCOVER)

Type 2 Diabetes Mellitus

Japan
AstraZeneca
Eli Lilly and Company

Completed

Study to Evaluate the Efficacy and Safety of Exenatide Once-Weekly Injection Compared to Once-Daily Insulin in Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

Japan
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin With or Without Metformin, in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes Mellitus

China, Thailand, Philippines, Singapore
Eli Lilly and Company

Completed

A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 Diabetes (SURPASS J-mono)

Type 2 Diabetes

Japan
GlaxoSmithKline

Completed

A Study to Determine the Long Term Safety and Efficacy of Albiglutide in Combination With Oral Monotherapy Antihyperglycemic Medications in Japanese Patients With Type 2 Diabetes Mellitus

Diabetes Mellitus

Japan
Throne Biotechnologies Inc.
Chinese PLA General Hospital

Unknown

Stem Cell Educator Therapy in Diabetes

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
Eli Lilly and Company

Completed

A Study of Basal Insulin Analog and Insulin Analog Mid Mixture in Chinese Participants With Type 2 Diabetes Mellitus (CLASSIC)

Type 2 Diabetes Mellitus

China
Ningbo No. 1 Hospital

Completed

Alcohol Consumption and Type 2 Diabetes Mellitus Risk in Nonalcoholic Fatty Liver Disease

Nonalcoholic Fatty Liver Disease | Type2 Diabetes Mellitus | Light-to-moderate Alcohol Consumption

China
Xiang Guang-da

Unknown

Chronic Cold Acclimation Stimulates the Browning of Subcutaneous White Adipose in Patients With Type 2 Diabetes Mellitus

Type 2 Diabetes | Cold Acclimation

China
Beijing Chao Yang Hospital
China development research foundation

Active, not recruiting

A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias (RCG)

Diabetes type2 | Hyperlipidemias | Hypertension,Essential

China
Eli Lilly and Company

Completed

Comparison of Insulin Mix25 Versus Mix50 (CLASSIFY)

Type 2 Diabetes Mellitus

Japan, Korea, Republic of, China, Turkey
Gilead Sciences

Completed

A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

Type 2 Diabetes Mellitus

United States, Russian Federation, Israel, South Africa, India, Hungary, Ukraine, Canada, Czech Republic, Mexico, Poland
Sanofi

Terminated

Efficacy and Safety of Sotagliflozin Versus Placebo in Chinese Patients With Type 2 Diabetes Mellitus Not Adequately Controlled by Metformin With or Without Sulfonylurea

Type 2 Diabetes Mellitus

China
Shandong University

Unknown

Autologous Bone Marrow Mononuclear Cells Transplantation in Treating Diabetes Patients

Diabetes Mellitus, Type 2 | Diabetes Mellitus, Type 1

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment

Type 2 Diabetes Mellitus | Mild Cognitive Impairment

China
The Affiliated Nanjing Drum Tower Hospital of Nanjing...

Recruiting

Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients

Type 2 Diabetes Mellitus | Cognitive Function Abnormal

China
Novo Nordisk A/S

Completed

Effect of Insulin Detemir on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
Shenzhen Salubris Pharmaceuticals Co., Ltd.

Completed

SAL067 Treatment in Patients With Type 2 Diabetes Who Are Not Controlled by Metformin

Diabetes Mellitus, Type 2

China
Chinese University of Hong Kong

Completed

Effectiveness of a Nurse-led Integrative Health and Wellness Programme Among Newly Diagnosed Type 2 Diabetes Patients (NIHaW)

Diabetes Mellitus, Type 2

China
Sanofi

Completed

Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (LixiLan) to Insulin Glargine Alone on Top of Oral Anti-diabetic Drugs (OADs) With Type 2 Diabetes in Japan (LIXILAN JP-O2)

Type 2 Diabetes Mellitus

Japan
Novo Nordisk A/S

Completed

Efficacy and Safety of Insulin Aspart in Subjects With Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

China
Astellas Pharma Inc

Terminated

Efficacy and Safety of Dorner Tablets and Aspirin for Prevention of Arteriosclerosis Progress in Type 2 Diabetes Mellitus Patients

Type 2 Diabetes Mellitus

China
Novo Nordisk A/S

Enrolling by invitation

Real-world Study of CHina Ozempic cLinicAl pRactice in Patients With Type 2 Diabetes (SCHOLAR) (SCHOLAR)

Diabetes Mellitus, Type 2

China
Novo Nordisk A/S

Completed

A Research Study to Look at How Insulin Icodec and Semaglutide Work in the Body of People From China With Type 2 Diabetes When Given Alone or Together

Diabetes Mellitus, Type 2

China
Novo Nordisk A/S

Completed

A Study to Test How a New Long-acting Insulin (Insulin Icodec) Works in the Body of People From China With Type 2 Diabetes

Diabetes Mellitus, Type 2

China
Novo Nordisk A/S

Completed

A Trial to Assess the Pharmacokinetics, Safety and Tolerability of Semaglutide in Healthy Chinese Subjects

Diabetes Mellitus, Type 2 | Diabetes

China
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Completed

Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes

Diabetes Mellitus, Type 2

China
RenJi Hospital
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine; ShiBei Hospital... and other collaborators

Unknown

Effects of Artificial Sweeteners on Glucose Metabolism in Patients With Type 2 Diabetes (SWEETS)

Diabetes Mellitus, Type 2

China
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 30 Combined With Metformin on Blood Glucose Control in Subjects With Type 2 Diabetes Inadequately Controlled With Basal Insulin

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Efficacy and Safety of Repaglinide and Metformin Combination Therapy in Type 2 Diabetes Failing on Oral Anti-diabetic Drugs

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Comparing the Efficacy and Safety of Biphasic Insulin Aspart 30 and Biphasic Human Insulin 30 on Blood Sugar Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Aspart 50 on Blood Glucose Control in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

An Observational Study Investigating the Safety and Effectiveness of Repaglinide in Chinese Patients (SAFE)

Diabetes Mellitus, Type 2 | Diabetes

China
Abbott Nutrition

Completed

An Intervention Program to Control Diabetes

Diabetes Mellitus, Type 2

China
Kowa Company, Ltd.
Sanofi

Completed

Tofogliflozin GLP-1 Analogue Combination Trial

Type 2 Diabetes Mellitus

Japan
GlaxoSmithKline

Completed

A Monotherapy Study to Evaluate the Efficacy and Safety of 2 Dose Levels of Albiglutide in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

Diabetes Mellitus, Type 2

Japan
Second Affiliated Hospital, School of Medicine,...

Recruiting

Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T1DM

Time in Range | HbA1c | Type 1 Diabetes Mellitus With Diabetic Gastroparesis

China
The Affiliated Hospital of Xuzhou Medical University

Recruiting

Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chinese Patients With T2DM

Type 2 Diabetes Mellitus | Susceptibility, Genetic

China
Chipscreen Biosciences, Ltd.

Completed

Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients (CMAP)

Type 2 Diabetes

China
Shanghai University of Traditional Chinese Medicine
Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Completed

the Integrated Traditional Chinese and Western Medicine Treat Early Stage DKD

Diabetic Nephropathy Type 2

China
Shanghai University of Traditional Chinese Medicine
Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Completed

the Integrated Traditional Chinese and Western Medicine Treat Middle Stage DKD

Diabetic Nephropathy Type 2

China

3

Subscribe